Form 8-K - Current report:
SEC Accession No. 0001493152-18-008474
Filing Date
2018-06-12
Accepted
2018-06-11 17:50:16
Documents
3
Period of Report
2018-06-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 32704
2 ex99-1.htm EX-99.1 18045
3 image_001.jpg GRAPHIC 4081
  Complete submission text file 0001493152-18-008474.txt   57872
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 18893008
SIC: 7389 Services-Business Services, NEC